Knocking down P32 reduced CHCHD2 expression in a CHCHD2-Arg145Gln mutant model and alleviated the PD-associated phenotype caused by the mutation, while protein expression remained unaffected in models expressing wild-type CHCHD2. The gene discussed is CHCHD2; the disease is Parkinson disease.